Relative Value

There is not enough data to reliably calculate the relative value of PCA.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PCA Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0.5
Median 5Y
0.5
Industry
4
vs History
vs Industry
Median 3Y
12.6
Median 5Y
-1.5
Industry
32
vs History
vs Industry
Median 3Y
-40.5
Median 5Y
-40.5
Industry
19.8
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-2.3
Industry
27.6
vs History
vs Industry
Median 3Y
15.3
Median 5Y
4.5
Industry
2.8
vs History
vs Industry
Median 3Y
0.8
Median 5Y
0.8
Industry
4
vs History
vs Industry
Median 3Y
2.1
Median 5Y
2.1
Industry
9
vs History
vs Industry
Median 3Y
-188.7
Median 5Y
-29.6
Industry
19.8
vs History
vs Industry
Median 3Y
-6.7
Median 5Y
-6.7
Industry
24.5
vs History
vs Industry
Median 3Y
-65.4
Median 5Y
-65.4
Industry
20.3
vs History
vs Industry
Median 3Y
-4
Median 5Y
-4
Industry
27.3
vs History
vs Industry
Median 3Y
0.7
Median 5Y
0.7
Industry
2.3

Multiples Across Competitors

PCA Competitors Multiples
Pcas SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Pcas SA
PAR:PCA
109.9m EUR 0.5 12.5 -188.7 -6.7
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 377.3 4 470.1 1 374.1 2 901.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
212.4B USD 4.9 32.3 23.1 29.9
US
Danaher Corp
NYSE:DHR
158.5B USD 6.5 45.2 24.3 36.8
CH
Lonza Group AG
SIX:LONN
36.4B CHF 5.1 49.8 37.9 37.9
US
Agilent Technologies Inc
NYSE:A
38.8B USD 5.6 29.8 23.1 27.5
US
IQVIA Holdings Inc
NYSE:IQV
37.9B USD 2.4 29.5 14.4 21.6
CN
WuXi AppTec Co Ltd
SSE:603259
259.1B CNY 5.8 17.3 19.7 19.7
KR
Samsung Biologics Co Ltd
KRX:207940
45.1T KRW 8.2 28.3 16.5 21.9
US
Mettler-Toledo International Inc
NYSE:MTD
28.4B USD 7.2 34 24.5 27.2
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.8B EUR 6.7 75.2 26.7 43.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Pcas SA
PAR:PCA
Average EV/EBITDA: 158.4
Negative Multiple: -188.7
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 374.1
5%
274.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
23.1
5%
4.6
US
Danaher Corp
NYSE:DHR
24.3
5%
4.9
CH
Lonza Group AG
SIX:LONN
37.9
18%
2.1
US
Agilent Technologies Inc
NYSE:A
23.1
13%
1.8
US
IQVIA Holdings Inc
NYSE:IQV
14.4
8%
1.8
CN
WuXi AppTec Co Ltd
SSE:603259
19.7
30%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
16.5
21%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
24.5
4%
6.1
FR
Sartorius Stedim Biotech SA
PAR:DIM
26.7
20%
1.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Pcas SA
PAR:PCA
Average EV/EBIT: 316.8
Negative Multiple: -6.7
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 901.2
29%
100
US
Thermo Fisher Scientific Inc
NYSE:TMO
29.9
15%
2
US
Danaher Corp
NYSE:DHR
36.8
16%
2.3
CH
Lonza Group AG
SIX:LONN
37.9
22%
1.7
US
Agilent Technologies Inc
NYSE:A
27.5
24%
1.1
US
IQVIA Holdings Inc
NYSE:IQV
21.6
15%
1.4
CN
WuXi AppTec Co Ltd
SSE:603259
19.7
23%
0.9
KR
Samsung Biologics Co Ltd
KRX:207940
21.9
28%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
27.2
5%
5.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
43.9
32%
1.4